4//SEC Filing
Shani Eli 4
Accession 0001209191-22-045351
CIK 0000818686other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 7:05 AM ET
Size
7.5 KB
Accession
0001209191-22-045351
Insider Transaction Report
Form 4
Shani Eli
EVP,Global Marketing&Portfolio
Transactions
- Exercise/Conversion
Restricted Share Units
2022-08-10−1,581→ 0 total→ Ordinary Shares (1,581 underlying) - Exercise/Conversion
Ordinary Shares
2022-08-10+1,581→ 19,741 total
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on August 10, 2018, with 1,581 vesting on August 10, 2022.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001876642
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 7:05 AM ET
- Size
- 7.5 KB